Cargando…

Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial

PURPOSE: To determine whether Mel4-coated antimicrobial contact lenses (MACLs) can reduce the incidence of corneal infiltrative events (CIEs) during extended wear. METHODS: A prospective, randomized, double-masked, single-center, contralateral, extended contact lens wear clinical trial was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalaiselvan, Parthasarathi, Konda, Nagaraju, Pampi, Nending, Vaddavalli, Pravin Krishna, Sharma, Savitri, Stapleton, Fiona, Kumar, Naresh, Willcox, Mark D. P., Dutta, Debarun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254012/
https://www.ncbi.nlm.nih.gov/pubmed/34191016
http://dx.doi.org/10.1167/tvst.10.7.32
_version_ 1783717638270091264
author Kalaiselvan, Parthasarathi
Konda, Nagaraju
Pampi, Nending
Vaddavalli, Pravin Krishna
Sharma, Savitri
Stapleton, Fiona
Kumar, Naresh
Willcox, Mark D. P.
Dutta, Debarun
author_facet Kalaiselvan, Parthasarathi
Konda, Nagaraju
Pampi, Nending
Vaddavalli, Pravin Krishna
Sharma, Savitri
Stapleton, Fiona
Kumar, Naresh
Willcox, Mark D. P.
Dutta, Debarun
author_sort Kalaiselvan, Parthasarathi
collection PubMed
description PURPOSE: To determine whether Mel4-coated antimicrobial contact lenses (MACLs) can reduce the incidence of corneal infiltrative events (CIEs) during extended wear. METHODS: A prospective, randomized, double-masked, single-center, contralateral, extended contact lens wear clinical trial was conducted with 176 subjects. Each participant was randomly assigned to wear a MACL in one eye and an uncoated control contact lens in the contralateral eye or an extended-wear biweekly disposable modality for 3 months. The main outcome measures were the incidence of CIEs per 100 eye-months, identification of the microbial types colonizing the contact lenses or eyes at the time of the CIEs, and their susceptibility to Mel4. RESULTS: Nine participants (5.1%) experienced unilateral CIEs; six participants had contact lens acute red eye, and three participants had infiltrative keratitis. The incidence rate for CIEs (0.4 events per 100 participant months; 1.7%) in the Mel4-coated lenses (test) was 69% less than that of the control lenses (1.3 events per 100 participant months; 3.4%; P = 0.29). All Gram-negative bacteria isolated from lenses and lids of participants with CIEs (Citrobacter diversus, Acinetobacter haemolyticus, and Acinetobacter lwoffii) were susceptible to Mel4 peptide; minimum inhibitory concentrations ranged from 15.6 to 62.5 µg/mL. Reduction of adhesion of these bacteria by Mel4-coated lenses ranged from 2.1 to 2.2 log(10) colony-forming units/lens. CONCLUSIONS: MACLs had the capacity to reduce CIEs by at least 50% compared with uncoated control lenses during extended wear over 3 months; however, due to the relatively low rates of CIEs, the reduction was not statistically different compared with control lenses. TRANSLATIONAL RELEVANCE: This study provides evidence that antimicrobial contact lenses have the potential to reduce the incidence of corneal infiltrative events during extended wear.
format Online
Article
Text
id pubmed-8254012
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-82540122021-07-08 Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial Kalaiselvan, Parthasarathi Konda, Nagaraju Pampi, Nending Vaddavalli, Pravin Krishna Sharma, Savitri Stapleton, Fiona Kumar, Naresh Willcox, Mark D. P. Dutta, Debarun Transl Vis Sci Technol Article PURPOSE: To determine whether Mel4-coated antimicrobial contact lenses (MACLs) can reduce the incidence of corneal infiltrative events (CIEs) during extended wear. METHODS: A prospective, randomized, double-masked, single-center, contralateral, extended contact lens wear clinical trial was conducted with 176 subjects. Each participant was randomly assigned to wear a MACL in one eye and an uncoated control contact lens in the contralateral eye or an extended-wear biweekly disposable modality for 3 months. The main outcome measures were the incidence of CIEs per 100 eye-months, identification of the microbial types colonizing the contact lenses or eyes at the time of the CIEs, and their susceptibility to Mel4. RESULTS: Nine participants (5.1%) experienced unilateral CIEs; six participants had contact lens acute red eye, and three participants had infiltrative keratitis. The incidence rate for CIEs (0.4 events per 100 participant months; 1.7%) in the Mel4-coated lenses (test) was 69% less than that of the control lenses (1.3 events per 100 participant months; 3.4%; P = 0.29). All Gram-negative bacteria isolated from lenses and lids of participants with CIEs (Citrobacter diversus, Acinetobacter haemolyticus, and Acinetobacter lwoffii) were susceptible to Mel4 peptide; minimum inhibitory concentrations ranged from 15.6 to 62.5 µg/mL. Reduction of adhesion of these bacteria by Mel4-coated lenses ranged from 2.1 to 2.2 log(10) colony-forming units/lens. CONCLUSIONS: MACLs had the capacity to reduce CIEs by at least 50% compared with uncoated control lenses during extended wear over 3 months; however, due to the relatively low rates of CIEs, the reduction was not statistically different compared with control lenses. TRANSLATIONAL RELEVANCE: This study provides evidence that antimicrobial contact lenses have the potential to reduce the incidence of corneal infiltrative events during extended wear. The Association for Research in Vision and Ophthalmology 2021-06-30 /pmc/articles/PMC8254012/ /pubmed/34191016 http://dx.doi.org/10.1167/tvst.10.7.32 Text en Copyright 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Article
Kalaiselvan, Parthasarathi
Konda, Nagaraju
Pampi, Nending
Vaddavalli, Pravin Krishna
Sharma, Savitri
Stapleton, Fiona
Kumar, Naresh
Willcox, Mark D. P.
Dutta, Debarun
Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial
title Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial
title_full Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial
title_fullStr Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial
title_full_unstemmed Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial
title_short Effect of Antimicrobial Contact Lenses on Corneal Infiltrative Events: A Randomized Clinical Trial
title_sort effect of antimicrobial contact lenses on corneal infiltrative events: a randomized clinical trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254012/
https://www.ncbi.nlm.nih.gov/pubmed/34191016
http://dx.doi.org/10.1167/tvst.10.7.32
work_keys_str_mv AT kalaiselvanparthasarathi effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT kondanagaraju effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT pampinending effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT vaddavallipravinkrishna effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT sharmasavitri effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT stapletonfiona effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT kumarnaresh effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT willcoxmarkdp effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial
AT duttadebarun effectofantimicrobialcontactlensesoncornealinfiltrativeeventsarandomizedclinicaltrial